IMIPENEM ANHYDROUS Pharmacologic Class Indexing
- Class set ID
- b3f20d80-e4b3-40ef-957e-f54f49c5286c
- Version
- 3
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use RECARBRIO safely and effectively. See full prescribing information for RECARBRIO. RECARBRIO ® (imipenem, cilastatin, and relebactam) for injection, for intravenous use Initial U.S. Approval: 2019 | Merck Sharp & Dohme LLC | 20251209 | 11 |
| These highlights do not include all the information needed to use IMIPENEM AND CILASTATIN FOR INJECTION safely and effectively. See full prescribing information for IMIPENEM AND CILASTATIN FOR INJECTION. IMIPENEM and CILASTATIN for injection, for intravenous use Initial U.S. Approval: 1985 | WG Critical Care, LLC | 20250116 | 8 |
| These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous use Initial U.S. Approval: 1985 | Merck Sharp & Dohme LLC | 20240705 | 34 |
| These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd | 20221011 | 5 |
| These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd | 20221010 | 7 |
| These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd | 20221006 | 12 |
| Imipenem | Merck Sharp & Dohme Corp. | 20171211 | 2 |